The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, AMN Healthcare Services Inc (NYSE: AMN) closed at $23.07 down -1.49% from its previous closing price of $23.42. In other words, the price has decreased by -$1.49 from its previous closing price. On the day, 1.72 million shares were traded.
Ratios:
For a deeper understanding of AMN Healthcare Services Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.85. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.31.
On October 07, 2024, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $65 to $48.
On December 06, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $85.JMP Securities initiated its Mkt Outperform rating on December 06, 2023, with a $85 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 02 ’24 when Knudson Jeffrey R sold 2,461 shares for $36.90 per share. The transaction valued at 90,811 led to the insider holds 37,550 shares of the business.
Caballero Jorge A. bought 2,000 shares of AMN for $113,600 on Mar 06 ’24. The Director now owns 2,437 shares after completing the transaction at $56.80 per share. On Mar 04 ’24, another insider, Fontenot Teri G., who serves as the Director of the company, bought 1,732 shares for $57.64 each. As a result, the insider paid 99,832 and bolstered with 4,558 shares of the company.
Valuation Measures:
As of this moment, AMN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.62, and their Forward P/E ratio for the next fiscal year is 15.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.98.
Stock Price History:
Over the past 52 weeks, AMN has reached a high of $79.49, while it has fallen to a 52-week low of $22.47. The 50-Day Moving Average of the stock is -10.42%, while the 200-Day Moving Average is calculated to be -45.68%.
Shares Statistics:
A total of 38.02M shares are outstanding, with a floating share count of 37.76M. Insiders hold about 0.82% of the company’s shares, while institutions hold 105.59% stake in the company.
Earnings Estimates
The market rating of AMN Healthcare Services Inc (AMN) is currently shaped by the ongoing analysis conducted by 9.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.31, with high estimates of $0.38 and low estimates of $0.2.
Analysts are recommending an EPS of between $3.16 and $2.92 for the fiscal current year, implying an average EPS of $3.04. EPS for the following year is $1.49, with 9.0 analysts recommending between $1.81 and $1.14.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $694.38M this quarter.It ranges from a high estimate of $697.16M to a low estimate of $691M. As of the current estimate, AMN Healthcare Services Inc’s year-ago sales were $818.27MFor the next quarter, 8 analysts are estimating revenue of $657.8M. There is a high estimate of $679.17M for the next quarter, whereas the lowest estimate is $639.1M.
A total of 8 analysts have provided revenue estimates for AMN’s current fiscal year. The highest revenue estimate was $2.95B, while the lowest revenue estimate was $2.94B, resulting in an average revenue estimate of $2.94B. In the same quarter a year ago, actual revenue was $3.79BBased on 8 analysts’ estimates, the company’s revenue will be $2.68B in the next fiscal year. The high estimate is $2.75B and the low estimate is $2.6B.
